AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies

NORTH CHICAGO, Ill. and CAMBRIDGE, Mass., Feb. 22, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Voyager Therapeutics, Inc. (Nasdaq: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced an…

United Airlines Taps Industry Veteran for Senior Role; Robert Rivkin Named SVP and General Counsel

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:”Arial”; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:”Arial”; color:black; } p.prnews_p { font-size:0.62em; font-family:”Arial”; color:black; margin:0in; } .prntac{ TEXT-ALIGN: CENTER } CHICAGO, Feb. 22, 2019 /PRNewswire/ — United Airlines today…

United Airlines Taps Industry Veteran for Senior Role; Robert Rivkin Named SVP and General Counsel

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:”Arial”; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:”Arial”; color:black; } p.prnews_p { font-size:0.62em; font-family:”Arial”; color:black; margin:0in; } .prntac{ TEXT-ALIGN: CENTER } CHICAGO , Feb. 22, 2019 /PRNewswire/ — United Airlines today…